Deals
SoftBank Plans to Invest Billions in Biotech Stocks
- Unit plans to invest in listed firms in biotech, health care
- Japanese firm has already made a number of equity investments
This article is for subscribers only.
SoftBank Group Corp. plans to expand its investments in the biotech and health-care sector, opening up a new front in its growing asset management strategy, according to people familiar with the matter.
SoftBank has already made a clutch of equity investments in the sector, including a $312 million stake in Pacific Biosciences of California Inc., a U.S. DNA-sequencing company whose stock has risen almost 9-fold in the last year. The Japanese firm is now planning to spend billions investing in public biotech companies, the people said, who asked not to speak publicly because the strategy is private.